• Shareholders approve all items on the agenda
  • Ratification of the actions of the Management Board and Supervisory Board by a large majority
  • Hermann Vogt re-elected as member of the Supervisory Board

Munich – The biosimilars company Formycon (ISIN: DE000A1EWVY8/ WKN: A1EWVY) held its Annual General Meeting on June 27, 2019.

At the Annual General Meeting, the shareholders represented followed the proposals of the Board of Management and the Supervisory Board and approved all resolutions proposed by the management with large majorities in each case. Both the members of the Board of Management and the Supervisory Board were given a vote of confidence by a majority of more than 95 percent each. Hermann Vogt, who had already been a member of the Supervisory Board since 2013 and acted as Deputy Chairman, was elected to the Supervisory Board with a large majority and for a further full term of office. In a subsequent constituent meeting, the Supervisory Board reappointed Dr. Olaf Stiller as Chairman and Mr. Hermann Vogt as Deputy Chairman.

At the time of the vote, around 4.4 million shares were represented, corresponding to 44.0% of the share capital. Detailed voting results and further information on the 2019 Annual General Meeting can be found at https://www.formycon.com/en/investor-relations/annual-general-meeting/.